#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the cervix Congenital ectodermal dysplasia Biliary neoplasm Gastrointestinal disorder Waldenstrom's macroglobulinaemia recurrent B-cell small lymphocytic lymphoma refractory Uterine leiomyosarcoma Endometrial cancer recurrent Systemic scleroderma Pyruvate kinase deficiency anaemia Paget's disease of the vulva Anal squamous cell carcinoma B-cell type acute leukaemia Turner's syndrome Iron overload More trials…

    Learn about Rare Diseases

    Nephroblastoma – Basic Information Retinitis pigmentosa – Basic Information Cholangitis sclerosing – Life with Disease Wiskott-Aldrich syndrome – Basic Information Krabbe’s disease – Basic Information Atypical haemolytic uraemic syndrome Glomerulonephritis rapidly progressive – Life with Disease Hypereosinophilic syndrome – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Mucopolysaccharidosis I – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    INCB123667 Hu5F9‐G4 Leucine Forimtamig Methionine VAMIFEPORT TRIHYDROCHLORIDE Trimetazidine Dihydrochloride Acemetacin Furosemide Ph. Eur. Fluorometholone Nofazinlimab Cefixime Protrans Disodium Levofolinate Abiraterone Acetate SP16 Litenimod Sodium Jnj-77242113 Cibotercept Vinorelbine More therapies…

    Learn about Your Condition

    Postoperative delirium Angiosarcoma Heart transplant Pericarditis Frontotemporal dementia Hyperoxaluria HER2 protein overexpression Cardiac failure Hypertonic bladder Behavioural addiction Erythema migrans Urethral valves Growth hormone deficiency Asplenia Microvillous inclusion disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Ptg-Carcik-Cd19
    Italy

  • Study of Intranasal Sufentanil and Intravenous Morphine for Severe Sickle Cell Pain Crisis in Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • Sufentanil
    • Morphine Hydrochloride
    • Sodium Chloride
    France

  • Study on the Safety of Mitapivat for Adults with Red Blood Cell Membrane Disorders

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Red blood cell abnormality
    Investigated Drugs:
    • Mitapivat
    Denmark The Netherlands

  • Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Venetoclax
    • Cytarabine
    • Daunorubicin
    Austria Belgium Estonia Finland Germany Lithuania +2

  • Study on Alpelisib for Treating Lymphatic Malformations in Patients with PIK3CA Mutation

    Recruiting

    4 1
    Investigated Diseases:
    • Lymphangioma
    Investigated Drugs:
    • Alpelisib
    Belgium Czechia France Germany Italy The Netherlands +1

  • Study on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Midostaurin
    • Cytarabine
    • Daunorubicin Hydrochloride
    Italy
Previous Page
1 … 29 30 31 32 33 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!